GlassScriptPhysician profile
Thomas Y Hung
NPI 1972592368
$6,630.97
in general payments reported to CMS, 2019-2025
20 companies · $2,398 in 2025
The $2,398 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $482 · 2021: $468 · 2022: $634 · 2023: $714 · 2024: $1,131 · 2025: $2,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,150 · Travel and Lodging: $93.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,150.27 |
| Travel and Lodging | $93.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,502.52 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Inspire Medical Systems, INC. | $1,465.73 | 2022-2025 | Inspire |
| Stryker Corporation | $956.97 | 2019-2025 | Scopis Ent, Clarifix |
| Aerin Medical INC. | $891.87 | 2019-2025 | |
| Intersect Ent, INC. | $459.18 | 2019-2021 | |
| Neurent Medical Limited | $351.96 | 2022 | |
| Spirair, INC. | $174.85 | 2024-2025 | Septalign |
| Acclarent, INC | $139.28 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $123.30 | 2021-2025 | Dupixent |
| Heron Therapeutics, INC. | $121.84 | 2023 | Zynrelef |
| Arbor Pharmaceuticals, INC. | $117.95 | 2019-2020 | |
| Genzyme Corporation | $85.22 | 2022-2025 | |
| Optinose US, INC. | $56.80 | 2021 | |
| Medtronic, INC. | $49.53 | 2024 | Signia, Propel |
| Olympus America INC. | $37.07 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $23.25 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.53 | 2023 | Iovera, Exparel |
| Novartis Pharmaceuticals Corporation | $20.52 | 2019 | |
| Sanara Medtech INC. | $17.90 | 2021 | |
| Arrinex, INC. | $14.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.